The development of antiplatelet therapy highlights the importance of understanding disease mechanisms, pharmacology, clinical experimentation, and luck in translational medicine.
Answers are grounded in this paper and cite their sources.
Supports mechanistic foundations of antiplatelet therapy; leaves open systematic strategies to integrate serendipity in cardiovascular translational research.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fitzgerald et al. (2013) conducted a review in Antiplatelet therapy development. Antiplatelet therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: